BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Urayama S. Pancreatic cancer early detection: Expanding higher-risk group with clinical and metabolomics parameters. World J Gastroenterol 2015; 21(6): 1707-1717 [PMID: 25684935 DOI: 10.3748/wjg.v21.i6.1707]
URL: https://www.wjgnet.com/1007-9327/full/v21/i6/1707.htm
Number Citing Articles
1
Nagendra Sastry Yarla, Olga Sukocheva, Ilaria Peluso, Swathi Putta, Pallaval Veera Bramhachari, Rajesh Yadala, Dinesh K. Tiwari, Srinivas Jagarlamudi, Luciana Scotti, Marcus T. Scotti, Marcella Reale, Mohammad Amjad Kamal, Ashraf Ghulam, Bechan Sharma, Madhukiran Parvathaneni, Chinthalapally V. Rao, Mastan Mannarapu, Anupam Bishayee. Role of Transcription Factors in Gastrointestinal Malignancies2017; : 403 doi: 10.1007/978-981-10-6728-0_30
2
Houria Boulaiz, María C. Ramos, Carmen Griñán-Lisón, Maria E. García-Rubiño, Francisca Vicente, Juan Antonio Marchal. What’s new in the diagnosis of pancreatic cancer: a patent review (2011-present)Expert Opinion on Therapeutic Patents 2017; 27(12): 1319 doi: 10.1080/13543776.2017.1379991
3
Kaiwei Xu, Zhoujian Qiu, Liu Xu, Xuedan Qiu, Lu Hong, Jianhua Wang. Increased Levels of Circulating Circular Rna (Hsa_Circ_0013587) May Serve As A Novel Biomarker for Pancreatic CancerBiomarkers in Medicine 2021; 15(12): 977 doi: 10.2217/bmm-2020-0750
4
Cecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, Roberta Curto, Claudia Curcio, Valeria Catanzaro, Giuseppe Digilio, Sergio Padovan, Maria Paola Puccinelli, Monica Isabello, Silvio Aime, Paola Cappello, Francesco Novelli. Endogenous glutamine decrease is associated with pancreatic cancer progressionOncotarget 2017; 8(56): 95361 doi: 10.18632/oncotarget.20545
5
Sumit Sahni, Advait R. Pandya, William J. Hadden, Christopher B. Nahm, Sarah Maloney, Victoria Cook, James A. Toft, Lorna Wilkinson‐White, Anthony J. Gill, Jaswinder S. Samra, Anthony Dona, Anubhav Mittal. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinomaInternational Journal of Cancer 2021; 148(6): 1508 doi: 10.1002/ijc.33368
6
Rui Zhao, Shuai Ren, Changyin Li, Kai Guo, Zipeng Lu, Lei Tian, Jian He, Kai Zhang, Yingying Cao, Shijia Liu, Donghui Li, Zhongqiu Wang. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter studyCancer Medicine 2023; 12(4): 5158 doi: 10.1002/cam4.5296
7
Barbara Wlodarczyk, Lukasz Durko, Konrad Walczak, Renata Talar-Wojnarowska, Ewa Malecka-Wojciesko. Select Endocrine Disorders and Exosomes in Early PDAC DiagnosisInternational Journal of Molecular Sciences 2024; 25(22): 12159 doi: 10.3390/ijms252212159
8
Clémentine Le Magnen, Aditya Dutta, Cory Abate-Shen. Optimizing mouse models for precision cancer preventionNature Reviews Cancer 2016; 16(3): 187 doi: 10.1038/nrc.2016.1
9
Neha Parveen, Afsana Sheikh, Mohammed A.S. Abourehab, Ritu Karwasra, Surender Singh, Prashant Kesharwani. Self-nanoemulsifying drug delivery system for pancreatic cancerEuropean Polymer Journal 2023; 190: 111993 doi: 10.1016/j.eurpolymj.2023.111993
10
Fan Yang, Dong-Yan Liu, Jin-Tao Guo, Nan Ge, Ping Zhu, Xiang Liu, Sheng Wang, Guo-Xin Wang, Si-Yu Sun. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancerWorld Journal of Gastroenterology 2017; 23(47): 8345-8354 doi: 10.3748/wjg.v23.i47.8345
11
Hayato Muranaka, Andrew Hendifar, Arsen Osipov, Natalie Moshayedi, Veronica Placencio-Hickok, Nicholas Tatonetti, Aleksandr Stotland, Sarah Parker, Jennifer Van Eyk, Stephen J. Pandol, Neil A. Bhowmick, Jun Gong. Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic CancerCancers 2023; 15(11): 3020 doi: 10.3390/cancers15113020
12
Munseok Choi, Minsu Park, Sung Hwan Lee, Min Jung Lee, Young‐Ki Paik, Sung Il Jang, Dong Ki Lee, Sang‐Guk Lee, Chang Moo Kang. Development of a metabolite calculator for diagnosis of pancreatic cancerCancer Medicine 2023; 12(15): 15933 doi: 10.1002/cam4.6233
13
S. Battini, F. Faitot, A. Imperiale, A. E. Cicek, C. Heimburger, G. Averous, P. Bachellier, I. J. Namer. Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patientsBMC Medicine 2017; 15(1) doi: 10.1186/s12916-017-0810-z
14
Tomas Koltai. Earlier Diagnosis of Pancreatic Cancer: Is It Possible?Cancers 2023; 15(18): 4430 doi: 10.3390/cancers15184430
15
Michael T. Zimmermann, Angela J. Mathison, Tim Stodola, Douglas B. Evans, Jenica L. Abrudan, Wendy Demos, Michael Tschannen, Mohammed Aldakkak, Jennifer Geurts, Gwen Lomberk, Susan Tsai, Raul Urrutia. Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort LevelFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.606820
16
Beste Turanli, Esra Yildirim, Gizem Gulfidan, Kazim Yalcin Arga, Raghu Sinha. Current State of “Omics” Biomarkers in Pancreatic CancerJournal of Personalized Medicine 2021; 11(2): 127 doi: 10.3390/jpm11020127
17
Jaroslav Tumas, Kotryna Kvederaviciute, Marius Petrulionis, Benediktas Kurlinkus, Arnas Rimkus, Greta Sakalauskaite, Jonas Cicenas, Audrius Sileikis. Metabolomics in pancreatic cancer biomarkers researchMedical Oncology 2016; 33(12) doi: 10.1007/s12032-016-0853-6
18
Bin Zhou, Jian‐Wei Xu, Yu‐Gang Cheng, Jing‐Yue Gao, San‐Yuan Hu, Lei Wang, Han‐Xiang Zhan. Early detection of pancreatic cancer: Where are we now and where are we going?International Journal of Cancer 2017; 141(2): 231 doi: 10.1002/ijc.30670
19
Jayasree Chakraborty, Liana Langdon-Embry, Kristen M. Cunanan, Joanna G. Escalon, Peter J. Allen, Maeve A. Lowery, Eileen M. O’Reilly, Mithat Gönen, Richard G. Do, Amber L. Simpson, Surinder K. Batra. Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patientsPLOS ONE 2017; 12(12): e0188022 doi: 10.1371/journal.pone.0188022
20
Haitao Zhao, Hannan Gao, Chuangwei Luo, Guangjie Yang, Xiaoyu Zhao, Shi Gao, Qingjie Ma, Bing Jia, Jiyun Shi, Fan Wang. An Integrin-αvβ6/α5β1-Bitargeted Probe for the SPECT Imaging of Pancreatic Adenocarcinoma in Preclinical and Primary Clinical StudiesBioconjugate Chemistry 2021; 32(7): 1298 doi: 10.1021/acs.bioconjchem.1c00296
21
Sarah Heiler, Zhe Wang, Margot Zöller. Pancreatic cancer stem cell markers and exosomes - the incentive pushWorld Journal of Gastroenterology 2016; 22(26): 5971-6007 doi: 10.3748/wjg.v22.i26.5971
22
Keith Unger, Khyati Y. Mehta, Prabhjit Kaur, Yiwen Wang, Smrithi S. Menon, Shreyans K. Jain, Rose A. Moonjelly, Shubhankar Suman, Kamal Datta, Rajbir Singh, Paul Fogel, Amrita K. Cheema. Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinomaOncotarget 2018; 9(33): 23078 doi: 10.18632/oncotarget.25212
23
Jie Sun, Fangfang Bi, Yang Yang, Yuan Zhang, Aihua Jin, Jinzi Li, Zhenhua Lin. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinomaOncology Reports 2017; 37(2): 857 doi: 10.3892/or.2016.5302
24
Ryota Nakano, Shin Nishiumi, Takashi Kobayashi, Takuya Ikegawa, Yuzo Kodama, Masaru Yoshida. Possibility of Detecting Intraductal Papillary Mucinous Neoplasms Using Metabolite Biomarkers for Pancreatic CancerBiomarkers in Medicine 2020; 14(11): 1009 doi: 10.2217/bmm-2019-0587
25
Hua Zhao, Amy B. Heimberger, Zhimin Lu, Xifeng Wu, Tiffany R. Hodges, Renduo Song, Jie Shen. Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypesOncotarget 2016; 7(15): 20486 doi: 10.18632/oncotarget.7974
26
Eerdunduleng Eerdunduleng. circ-LDLRAD3 regulates cell proliferation, migration and invasion of pancreatic cancer by miR-876-3p/STAT3Clinical Surgery Research Communications 2019; 1(1): 08 doi: 10.31491/CSRC.2019.03.027
27
Seoung Yoon Rho, Sang-Guk Lee, Minsu Park, Jinae Lee, Sung Hwan Lee, Ho Kyoung Hwang, Min Jung Lee, Young-Ki Paik, Woo Jung Lee, Chang Moo Kang. Developing a preoperative serum metabolome-based recurrence-predicting nomogram for patients with resected pancreatic ductal adenocarcinomaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-55016-x